Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
NBIX
ACCE ResearchedNeurocrine Biosciences Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericNASDAQ
$131.78
+0.08%today
MKT CAP
$13.3B
NEXT EARNINGS
May 5
Analysis in progress.
+20.1% · 1Y
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.